Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Precision Medicine in Gynecologic Cancers: Expert Answers to Your Questions

In this podcast episode, listen to Linda R. Duska, MD, MPH; Robert L. Coleman, MD, FACOG, FACS; and Leslie Randall, MD, MAS, as they answer questions on managing patients with endometrial or ovarian cancers based on the latest evidence.
Robert L. Coleman, MD, FACOG, FACS
Linda R. Duska, MD, MPH
Leslie M. Randall, MD, MAS, FACS
Released: July 12, 2021

In this episode, Linda R. Duska, MD, MPH; Robert L. Coleman, MD, FACOG, FACS; and Leslie Randall, MD, MAS, answer questions from an audience of healthcare professionals on topics related to the management of patients with endometrial and ovarian cancer including:  

  • Adding bevacizumab to chemotherapy in frontline endometrial cancer
  • Lenvatinib and pembrolizumab in MSI-H/dMMR endometrial cancer
  • PARP inhibitor maintenance in ovarian cancer
  • Bevacizumab with or without PARP inhibitors in ovarian cancer

Presenters:

Linda R. Duska, MD, MPH
Lawrence W. Penniston MD Family Professor in Women’s Oncology Research
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Robert L. Coleman, MD, FACOG, FACS
Gynecologic Oncologist and Chief Scientific Officer
US Oncology, US Oncology Research
The Woodlands, Texas

Leslie Randall, MD, MAS 
Diane Harris Wright Professor and Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
Massey Cancer Center
Virginia Commonwealth University
Richmond, Virginia

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
GlaxoSmithKline

Related Content

Virtual presentation by Shannon N. Westin, MD, MPH, on improving health equity for patients with endometrial cancer, from Clinical Care Options (CCO)

Shannon N. Westin, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 17, 2021 Expired: September 16, 2022

Downloadable slideset updated with highlights of key gynecologic oncology studies presented at conferences throughout 2021, from Clinical Care Options (CCO)

Jubilee Brown, MD Melissa M. Hardesty, MD, MPH person default Alexandra Leary, MD, PhD Domenica Lorusso, MD, PhD Ursula Matulonis, MD David Scott Miller, MD, FACOG, FACS Released: September 15, 2021

Gain key clinical insights quickly with this short slideset from CCO on the latest treatment, challenges and future directions for the management of ovarian cancer using PARPi.

Nicoletta Colombo, MD person default Philipp Harter, MD, PhD person default Alexandra Leary, MD, PhD Released: September 10, 2021

Slides from Shannon N. Westin, MD, MPH, on improving outcomes for all women with endometrial cancer using precision medicine and guideline-recommended care, from Clinical Care Options (CCO)

Shannon N. Westin, MD, MPH Released: September 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue